Signal #128857 · SEC 8-K

$QURE SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $QURE filing catalyst

Why did $QURE trigger an AI stock catalyst alert?

$QURE triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: uniQure Reports Q3 2026: FDA Grants Priority Review for AMT-130, Cash Runway into 2030. Key points: - FDA granted Priority Review for AMT-130 BLA with a PDUFA target action date of May 1, 2027 - Cash, equivalents and investments stand at $768.4M, providing runway into 2030 - Q3 revenue at $5.2M vs $3.7M YoY; net loss narrowed to $61.2M ($0.88/share) from $80.5M ($1.38/share)

How did $QURE stock react after the SEC filing?

After the SEC 8-K for $QURE, observed market reaction: T0 price $23.87. Past moves do not guarantee future results.

Where can I get real-time $QURE SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $QURE via Telegram and the VIP Web Terminal from €10/month.

$QURE

$QURE – uniQure Reports Q3 2026: FDA Grants Priority Review for AMT-130, Cash Runway into 2030

uniQure N.V.

2026-11-04 00:00:00 UTC · SEC 8-K · All $QURE

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+6.5 / 10)

FDA granted Priority Review for AMT-130 BLA with a PDUFA target action date of May 1, 2027
Cash, equivalents and investments stand at $768.4M, providing runway into 2030
Q3 revenue at $5.2M vs $3.7M YoY; net loss narrowed to $61.2M ($0.88/share) from $80.5M ($1.38/share)

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →